发明名称 |
COMBINATION THERAPY FOR THE TREATMENT OF CANCER. |
摘要 |
The present disclosure relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is an anti-hormonal agent or a pharmaceutically acceptable salt thereof. The present disclosure also relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof, (2) a second agent which is an anti-hormonal agent or a pharmaceutically acceptable salt thereof, and (3) a third agent which is an agent that regulates the PI3K/Akt/mTOR pathway or a pharmaceutically acceptable salt thereof. |
申请公布号 |
MX2016001793(A) |
申请公布日期 |
2016.05.18 |
申请号 |
MX20160001793 |
申请日期 |
2014.08.07 |
申请人 |
NOVARTIS AG |
发明人 |
SUNKYU KIM;XIZHONG HUANG;YAN CHEN |
分类号 |
A61K31/519;A61K31/551;A61P35/00 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|